One hundred forty low risk pregnant women scheduled for elective cesarean delivery were randomized (1:1) into two groups: the intrauterine group (n=70) received 400 μg misoprostol (200 μg at each uterine cornu) after placental delivery, while the rectal group (n=70) received 400 μg misoprostol rectally via urinary catheter insertion preoperatively.
Inclusion Criteria:
Exclusion Criteria:
400 μg of misoprostol (Cytotec, Pfizer, G.D. Searle LLC) administered intrauterinely after placental delivery during cesarean section. The dose was divided as 200 μg placed at each uterine cornu.
400 μg of misoprostol administered rectally via urinary catheter insertion preoperatively.
Cairo, Cairo Governorate 12111, Egypt
Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section
Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section
Comparative Study Between the Roles of Intrauterine Misoprostol Versus the Sublingual Route for Prevention of Postpartum Blood Loss in Elective Cesarean Sections
Comparative Study Between Preoperative and Postoperative Rectal Misoprostol
Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?
Intrauterine Misoprostol Versus Intravenous Oxytocin Infusion During Cesarean Delivery
Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss
Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery